WRN and colorectal cancer: A provocative paper published in 1996 led us to pursue another productive, clinically important line of WS research: Esteller and colleagues claimed that WRN gene silencing was common in human epithelial malignancies, and that WRN loss was a major determinant of treated outcomes in advanced stage colorectal cancers [51].